About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Implanted Continuous Glucose Monitoring is Safe and Accurate

by Hannah Joy on February 13, 2018 at 1:16 PM
Font : A-A+

Implanted Continuous Glucose Monitoring is Safe and Accurate

Implantable Eversense continuous glucose monitoring (CGM) system was found to be safe and accurate through the intended 90-day sensor life in patients with type 1 and type 2 diabetes.

More than 93 percent of CGM glucose values were within an acceptable range of reference values, according to the PRECISE II data reported in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Advertisement


Lynne Kelley, MD, Senseonics, Inc. (Germantown, MD), and a team of clinical researchers from across the United States conducted the prospective, multicenter PRECISE II study.

They describe the study design and their findings in the article entitled "A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II."
Advertisement

The primary endpoint of the study was the mean absolute relative difference (MARD) between Eversense glucose values and reference measurements (from 40-400 mg/dL) over the 90-day post-insertion period.

The researchers showed that clinicians with limited to no surgical experience could safely insert and remove the CGM sensor after appropriate training. Only one serious adverse event was reported related to device use or sensor insertion/removal.

"Continuous glucose monitoring is becoming standard of care especially for insulin-requiring patients with diabetes. Eversense, if approved by the FDA, will become the first implantable CGM system for use lasting at least 3 months," says DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver (Aurora).



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetes - Foot Care Sugar: Time to Look beyond Its Sweetness Diabetic Ketoacidosis 

Recommended Reading
FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System
Animas Corporation has announced Food and Drug Administration (FDA) approval of the Animas Vibe ......
Dexcom G5 Mobile Continuous Glucose Monitoring System Receives CE Mark
The device offers wireless Bluetooth technology housed in the device transmitter that allows ......
Medtronic’s Continuous Glucose Monitoring System Receives FDA Approval
Medtronic has revealed that it has received approval from the FDA for its next generation ......
Continuous Glucose Monitoring may Benefit Diabetes Patients
Continuous real-time glucose monitoring could benefit patients with diabetes....
Diabetes - Foot Care
Valuable information on diabetic foot care, treatment and prevention....
Diabetic Ketoacidosis
Diabetic ketoacidosis (DKA) is a dangerous complication of uncontrolled diabetes which manifests wit...
Sugar: Time to Look beyond Its Sweetness
Sugar is known to be the dietary cause for increased risk of several chronic ailments such as diabet...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use